Total bilirubin ≤1.5 x ULN (<3 x ULN for patients with liver involvement). Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) ≤2.5 x ULN (≤5 x ULN for patients with liver involvement from breast cancer).